Clinical Outcome Measure at Stryker Spine
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- VB Spine, LLC
- Study ID
- NCT06226272
- Status
- Recruiting
Conditions
- Degenerative Disc Disease
- Degenerative Scoliosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Spinal Fusion — DEVICECervical Spinal Fusion
- Spinal Fusion — DEVICEThoracic / Lumbar Spinal Fusion
- Spinal Deformities Correction — DEVICESpinal Deformities Correction
Study Details
This is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to Stryker cleared Instructions for Use (IFU).
Key Dates
- Start date
- Jan 28, 2025
- Status verified
- Jun 2026
- Primary completion
- Jan 29, 2029
- Completion
- Jan 29, 2032
Study Design
- Enrollment
- 5,222 participants (estimated)
Arms
- Arm: S-S-102-A: Cervical Sub-ProtocolThe study population includes subjects who are surgically treated with a Stryker device for a cervical condition per the specific device cleared IFUs and Surgical Technique Guides (STGs), by a participating investigator and are willing to complete patient-reported questionnaires at the study-specific time points.
- Arm: S-S-102-B: Thoracolumbar Sub-ProtocolThe study population includes subjects who are surgically treated with a Stryker device for a thoracic/lumbar condition per the specific device cleared IFUs and STGs, by a participating investigator and are willing to complete patient-reported questionnaires at the study-specific time points.
- Arm: S-S-102-C: Adult Spinal DeformitiesThe study population includes subjects who are surgically treated with a Stryker device for a spinal deformity condition per the specific device cleared IFUs and STGs, by a participating investigator and are willing to complete patient-reported questionnaires at the study-specific time points.
Primary Outcome Measure
S-S-102-A [ Time Frame: Baseline through 24-months post-op. ]
Central Contacts
- Mary Majer866-526-4171
- Effa Gyamfi866-526-4171
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | Megan Gauthier Stephen Pirris, MD (PRINCIPAL_INVESTIGATOR) |
| MaineHealth Neurosurgery and Spine | Scarborough | Maine | 04074 | Chelsea Ruel Robert D. Ecker, MD (PRINCIPAL_INVESTIGATOR) |
| Michigan Orthopaedic Surgeons | Southfield | Michigan | 48033 | Reily Nesson Jad Khalil, MD (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinc | Cleveland | Ohio | 44195 | Ghaith Habboub, MD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Richard Call Amir M Abtahi, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Spine & Scoliosis | Austin | Texas | 78705 | Devender Singh, PhD Eeric Truumees, MD (PRINCIPAL_INVESTIGATOR) |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | Keyla Guevara James E. Showery, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- Advanced Materials Science in XLIF StudyEnrolling By Invitation · NuVasive · Hartford, Connecticut
- Lumbar Interbody Implant StudyEnrolling By Invitation · NuVasive · La Jolla, California
- Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar FusionRecruiting · Kuros Biosurgery AG · Irvine, California
- Cervical Interbody Implant StudyEnrolling By Invitation · NuVasive · Orange, California